- Home
- BPMC vs UBSI Comparison
BPMC vs UBSI Comparison
Compare BPMC & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- UBSI
- Stock Information
- Founded
- BPMC 2008
- UBSI 1982
- Country
- BPMC United States
- UBSI United States
- Employees
- BPMC N/A
- UBSI N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- UBSI Major Banks
- Sector
- BPMC Health Care
- UBSI Finance
- Exchange
- BPMC Nasdaq
- UBSI Nasdaq
- Market Cap
- BPMC 5.8B
- UBSI 5.3B
- IPO Year
- BPMC 2015
- UBSI N/A
- Fundamental
- Price
- BPMC $128.20
- UBSI $34.93
- Analyst Decision
- BPMC Buy
- UBSI Hold
- Analyst Count
- BPMC 20
- UBSI 4
- Target Price
- BPMC $127.82
- UBSI $40.13
- AVG Volume (30 Days)
- BPMC 6.4M
- UBSI 566.6K
- Earning Date
- BPMC 07-31-2025
- UBSI 07-24-2025
- Dividend Yield
- BPMC N/A
- UBSI 4.25%
- EPS Growth
- BPMC N/A
- UBSI 2.88
- EPS
- BPMC N/A
- UBSI 2.70
- Revenue
- BPMC $562,121,000.00
- UBSI $1,021,155,000.00
- Revenue This Year
- BPMC $44.46
- UBSI $20.44
- Revenue Next Year
- BPMC $32.78
- UBSI $5.18
- P/E Ratio
- BPMC N/A
- UBSI $12.90
- Revenue Growth
- BPMC 99.19
- UBSI 0.82
- 52 Week Low
- BPMC $73.04
- UBSI $30.51
- 52 Week High
- BPMC $128.34
- UBSI $44.43
- Technical
- Relative Strength Index (RSI)
- BPMC 75.62
- UBSI 42.54
- Support Level
- BPMC $127.86
- UBSI $34.34
- Resistance Level
- BPMC $128.33
- UBSI $37.25
- Average True Range (ATR)
- BPMC 0.41
- UBSI 0.63
- MACD
- BPMC -0.32
- UBSI -0.24
- Stochastic Oscillator
- BPMC 84.62
- UBSI 20.27
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.